Amino Acid Neurotransmitter Deficits in Adult Down's Syndrome Brain Tissue

Overview

Journal Neurosci Lett

Specialty Neurology

Date 1988 Nov 22

PMID 2907377

Citations 24

Authors

G P Reynolds

C E Warner

Affiliations

Soon will be listed here.

Abstract

Neurotransmitter amino acids have been measured in several brain regions taken postmortem from 5 adults cases of Down's syndrome and 6 age-matched control subjects. A significant deficit of glutamate was found in the hippocampus in Down's syndrome, and gamma-aminobutyric acid was reduced in the hippocampus and temporal cortex in those patients with neocortical neurofibrillary tangles. These results are consistent with losses of cortical neurones containing these neurotransmitters, and resemble the deficits exhibited by the more severely affected cases of Alzheimer's disease.

Citing Articles

ZBTB21 suppresses CRE-mediated transcription to impair synaptic function in Down syndrome.

Qiao M, Huang Q, Wang X, Han J Sci Adv. 2024; 10(27):eadm7373.

PMID: 38959316 PMC: 11221507. DOI: 10.1126/sciadv.adm7373.

Deficits in neuronal architecture but not over-inhibition are main determinants of reduced neuronal network activity in a mouse model of overexpression of Dyrk1A.

Manubens-Gil L, Pons-Espinal M, Gener T, Ballesteros-Yanez I, Martinez de Lagran M, Dierssen M Cereb Cortex. 2023; 34(1).

PMID: 37997361 PMC: 10793573. DOI: 10.1093/cercor/bhad431.

Understanding the genetic mechanisms and cognitive impairments in Down syndrome: towards a holistic approach.

Abukhaled Y, Hatab K, Awadhalla M, Hamdan H J Neurol. 2023; 271(1):87-104.

PMID: 37561187 PMC: 10769995. DOI: 10.1007/s00415-023-11890-0.

The innate immune system stimulating cytokine GM-CSF improves learning/memory and interneuron and astrocyte brain pathology in Dp16 Down syndrome mice and improves learning/memory in wild-type mice.

Ahmed M, Wang A, Elos M, Chial H, Sillau S, Solano D Neurobiol Dis. 2022; 168:105694.

PMID: 35307513 PMC: 9045510. DOI: 10.1016/j.nbd.2022.105694.

Rethinking Intellectual Disability from Neuro- to Astro-Pathology.

Fernandez-Blanco A, Dierssen M Int J Mol Sci. 2020; 21(23).

PMID: 33261169 PMC: 7730506. DOI: 10.3390/ijms21239039.